QuintilesIMS Chairman & CEO Ari Bousbib to Speak at J.P. Morgan Ultimate Services Conference on November 15

November 08, 2016
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C. -- QuintilesIMS (NYSE:Q) announced today that Ari Bousbib, chairman and chief executive officer, will participate in a “fireside chat” at the J.P. Morgan Ultimate Services Conference in New York City on Tuesday, November 15, 2016 at 1:15 p.m. Eastern Time.

A live audio webcast of the session will be available on the QuintilesIMS Investor Relations website at http://ir.quintilesims.com. A replay of the webcast also will be available on the website later that day.

About QuintilesIMS
QuintilesIMS (NYSE:Q) is a leading integrated information and technology-enabled healthcare service provider worldwide, dedicated to helping its clients improve their clinical, scientific and commercial results. Formed through the merger of Quintiles Transnational and IMS Health, QuintilesIMS’s approximately 50,000 employees conduct operations in more than 100 countries. Companies seeking to improve real-world patient outcomes through treatment innovations, care provision and access can leverage QuintilesIMS’s broad range of healthcare information, technology and service solutions to drive new insights and approaches. QuintilesIMS provides solutions that span clinical to commercial, bringing customers a unique opportunity to realize the full potential of innovations and advanced healthcare outcomes.

As a global leader in protecting individual patient privacy, QuintilesIMS uses healthcare data to deliver critical, real-world disease and treatment insights. Through a wide variety of privacy-enhancing technologies and safeguards, QuintilesIMS protects individual privacy while managing information to drive healthcare forward. These insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders in the development and approval of new therapies, and to identify unmet treatment needs and understand the safety, effectiveness and value of pharmaceutical products in improving overall health outcomes. To learn more, visit www.QuintilesIMS.com.

Investor Relations Contacts:
Tom Kinsley, 203-448-4691
thomas.kinsley@quintilesims.com

or

Andrew Markwick, 973-257-7144
andrew.markwick@quintilesims.com

Media Relations Contacts:
Tor Constantino, 484-567-6732
tor.constantino@quintilesims.com

or

Phil Bridges, 919-998-1653
Mobile: 919-457-6347
phil.bridges@quintilesims.com